Sonnet BioTherapeutics Holdings, Inc. (SONN)
Dec 2, 2025 - SONN was delisted (reason: merged into PURR)
1.260
-1.840 (-59.35%)
Inactive · Last trade price on Dec 2, 2025
SONN Revenue
Sonnet BioTherapeutics Holdings had revenue of $1.00M in the twelve months ending June 30, 2025, up 1,689.52% year-over-year. In the fiscal year ending September 30, 2024, Sonnet BioTherapeutics Holdings had annual revenue of $18.63K, down -87.40%.
Revenue (ttm)
$1.00M
Revenue Growth
+1,689.52%
P/S Ratio
3.41
Revenue / Employee
$76,923
Employees
13
Market Cap
8.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 18.63K | -129.18K | -87.40% |
| Sep 30, 2023 | 147.81K | -202.14K | -57.76% |
| Sep 30, 2022 | 349.94K | -133.68K | -27.64% |
| Sep 30, 2021 | 483.63K | - | - |
| Sep 30, 2020 | - | - | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition